The human gut microbiota: Metabolism and perspective in obesity

By A. Gomes, Christian Hoffmann, J. F. Mota. Gut microbes, 2018

665 citations recorded by the source corpus.

ABSTRACT The gut microbiota has been recognized as an important factor in the development of metabolic diseases such as obesity and is considered an endocrine organ involved in the maintenance of energy homeostasis and host immunity. Dysbiosis can change the functioning of the intestinal barrier and the gut-associated lymphoid tissues (GALT) by allowing the passage of structural components of bacteria, such as lipopolysaccharides (LPS), which activate inflammatory pathways that may contribute to the development of insulin resistance. Furthermore, intestinal dysbiosis can alter the production of gastrointestinal peptides related to satiety, resulting in an increased food intake. In obese people, this dysbiosis seems be related to increases of the phylum Firmicutes, the genus Clostridium, and the species Eubacterium rectale, Clostridium coccoides, Lactobacillus reuteri, Akkermansia muciniphila, Clostridium histolyticum, and Staphylococcus aureus.

Subfields: Food Science, Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/9e01bdfc9eae7045c71847e1744ce8ae03de6474

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Sarkar
2. S. Dutra
3. D. McSkimming
4. M. Groer
5. Ji Youn Yoo

Citations in the corpus

• Gut Microbiota and Immune System Interactions (2020, background): “Moreover, IgA binds to M-cells, a cell population present in the epithelium overlying PPs and specialized in the gut luminal across the epithelium [58,59].”